Randomised clinical trial: rabeprazole plus aspirin is not inferior to rabeprazole plus clopidogrel for the healing of aspirin-related peptic ulcer
نویسندگان
چکیده
منابع مشابه
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease.
BACKGROUND Aspirin is the prophylactic antiplatelet drug of choice for people with cardiovascular disease. However, protection with antiplatelet therapy in people with a high risk of cardiovascular disease is unsatisfactory in absolute terms. Adding a second antiplatelet drug to aspirin may produce additional benefit for those at high risk and those with established cardiovascular disease. OB...
متن کاملClopidogrel Plus Aspirin for Stroke Prevention
Stroke Prevention To the Editor: We are responding to the review by Drs Albers and Amarenco about the use of clopidogrel plus aspirin for patients with cerebrovascular disease.1 We view the results of the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study, added to all of the clopidogrel data, as more supportive of the combination of clopidogrel plus aspirin in stroke-threa...
متن کاملClopidogrel plus aspirin for stroke prevention.
Stroke Prevention To the Editor: We are responding to the review by Drs Albers and Amarenco about the use of clopidogrel plus aspirin for patients with cerebrovascular disease.1 We view the results of the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study, added to all of the clopidogrel data, as more supportive of the combination of clopidogrel plus aspirin in stroke-threa...
متن کاملClopidogrel plus aspirin was inferior to oral anticoagulation for preventing vascular events in atrial fibrillation.
M e t h o d s Design: Randomized controlled trial (Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events [ACTIVE W]). Allocation: Concealed.* Blinding: Blinded (outcome assessors and monitoring committee).* Follow-up period: Median 1.28 years. Setting: 30 clinical centers worldwide. Patients: 6706 patients (mean age 70 y, 66% men) with AF and ≥ 1 of the followi...
متن کاملAspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial
Methods We did a randomised controlled trial in which we assigned patients to aspirin (30–325 mg daily) with (n=1363) or without (n=1376) dipyridamole (200 mg twice daily) within 6 months of a transient ischaemic attack or minor stroke of presumed arterial origin. Our primary outcome event was the composite of death from all vascular causes, non-fatal stroke, non-fatal myocardial infarction, or...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Alimentary Pharmacology & Therapeutics
سال: 2011
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2011.04760.x